A phase II study of a novel gemcitabine plus cisplatin regimen administered every three weeks for advanced non-small-cell lung cancer

  1. Castellano, D.
  2. Lianes, P.
  3. Paz-Ares, L.
  4. Hidalgo, M.
  5. Guerra, J.A.
  6. Gómez-Martín, C.
  7. Gómez, H.
  8. Calzas, J.
  9. Cortés-Funes, H.
Revue:
Annals of Oncology

ISSN: 0923-7534

Année de publication: 1998

Volumen: 9

Número: 4

Pages: 457-459

Type: Article

DOI: 10.1023/A:1008276507236 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus